Terms: = Lymphoma AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
74 results:
1. Transcriptome Analysis in Mexican Adults with Acute Lymphoblastic Leukemia.
Cruz-Miranda GM; Olarte-Carrillo I; Bárcenas-López DA; Martínez-Tovar A; Ramírez-Bello J; Ramos-Peñafiel CO; García-Laguna AI; Cerón-Maldonado R; May-Hau D; Jiménez-Morales S
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339034
[TBL] [Abstract] [Full Text] [Related]
2. Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells.
Feng Q; Hu K; Hu H; Lu Y; Zhang H; Wang G; Zhang Q; Xu Z; Gao X; Jia X; Zhu H; Song D; Yi H; Peng Y; Wu X; Li B; Zhu W; Shi J
Int Immunopharmacol; 2023 Dec; 125(Pt A):111139. PubMed ID: 37913572
[TBL] [Abstract] [Full Text] [Related]
3. Conferone, a coumarin from
Rafatpanah H; Golizadeh M; Mahdifar M; Mahdavi S; Iranshahi M; Rassouli FB
Int J Immunopathol Pharmacol; 2023; 37():3946320231197592. PubMed ID: 37688389
[TBL] [Abstract] [Full Text] [Related]
4. [In vitro pharmacodynamic studies of novel class Ⅰ and Ⅱb selective histone deacetylase inhibitor purinostat mesylate in the treatment of diffuse large B-cell lymphoma and its mechanism].
Wang J; Zhao AL; Li H; Yang LY; Chen LJ; Niu T
Zhonghua Xue Ye Xue Za Zhi; 2022 Sep; 43(9):753-759. PubMed ID: 36709169
[No Abstract] [Full Text] [Related]
5. [Cell Cycle Arrest and Apoptosis Induced by Atovaquone in Non-Hodgkin's lymphoma Raji Cells].
Chen CY; Shen X; Xing S; Zhang XW; Jiang G; Yu ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1746-1751. PubMed ID: 36476898
[TBL] [Abstract] [Full Text] [Related]
6. Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study.
Kuruvilla J; Armand P; Hamadani M; Kline J; Moskowitz CH; Avigan D; Brody JD; Ribrag V; Herrera AF; Morschhauser F; Kanate A; Zinzani PL; Bitran J; Ghesquieres H; Schuster SJ; Farooqui M; Marinello P; Bartlett NL
Leuk Lymphoma; 2023 Jan; 64(1):130-139. PubMed ID: 36398795
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of DEK Enhances Doxorubicin-Induced Apoptosis and Cell Cycle Arrest in T-Cell Acute Lymphoblastic Leukemia Cells.
Tian X; Zhu Z; Wang G; Xu J; Liang A; Zhang W
Dis Markers; 2022; 2022():9312971. PubMed ID: 35769815
[TBL] [Abstract] [Full Text] [Related]
8. Targeted inhibitors and antibody immunotherapies: Novel therapies for paediatric leukaemia and lymphoma.
Brivio E; Baruchel A; Beishuizen A; Bourquin JP; Brown PA; Cooper T; Gore L; Kolb EA; Locatelli F; Maude SL; Mussai FJ; Vormoor-Bürger B; Vormoor J; von Stackelberg A; Zwaan CM
Eur J Cancer; 2022 Mar; 164():1-17. PubMed ID: 35121370
[TBL] [Abstract] [Full Text] [Related]
9. Genome-wide CRISPR screen identifies cdk6 as a therapeutic target in adult T-cell leukemia/lymphoma.
Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
[TBL] [Abstract] [Full Text] [Related]
10. Targeting the cdk6 Dependence of Ph+ Acute Lymphoblastic Leukemia.
Porazzi P; De Dominici M; Salvino J; Calabretta B
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573335
[TBL] [Abstract] [Full Text] [Related]
11. DNA binding and evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes.
Zhang Y; Zhou Y; Zhang H; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Nov; 224():111580. PubMed ID: 34438219
[TBL] [Abstract] [Full Text] [Related]
12. T Cell-Intrinsic cdk6 Is Dispensable for Anti-Viral and Anti-Tumor Responses
Klein K; Witalisz-Siepracka A; Gotthardt D; Agerer B; Locker F; Grausenburger R; Knab VM; Bergthaler A; Sexl V
Front Immunol; 2021; 12():650977. PubMed ID: 34248938
[TBL] [Abstract] [Full Text] [Related]
13. Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/cdk6 signaling pathway.
Gu J; Wang X; Zhang L; Xiang J; Li J; Chen Z; Zhang Y; Chen J; Shen J
BMC Complement Med Ther; 2021 Jun; 21(1):163. PubMed ID: 34088288
[TBL] [Abstract] [Full Text] [Related]
14. Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on
Silvestri G; Trotta R; Stramucci L; Ellis JJ; Harb JG; Neviani P; Wang S; Eisfeld AK; Walker CJ; Zhang B; Srutova K; Gambacorti-Passerini C; Pineda G; Jamieson CHM; Stagno F; Vigneri P; Nteliopoulos G; May PC; Reid AG; Garzon R; Roy DC; Moutuou MM; Guimond M; Hokland P; Deininger MW; Fitzgerald G; Harman C; Dazzi F; Milojkovic D; Apperley JF; Marcucci G; Qi J; Polakova KM; Zou Y; Fan X; Baer MR; Calabretta B; Perrotti D
Blood Cancer Discov; 2020 Jul; 1(1):48-67. PubMed ID: 32974613
[TBL] [Abstract] [Full Text] [Related]
15. The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.
Baldi GG; Brahmi M; Lo Vullo S; Cojocaru E; Mir O; Casanova M; Vincenzi B; De Pas TM; Grignani G; Pantaleo MA; Blay JY; Jones RL; Le Cesne A; Frezza AM; Gronchi A; Collini P; Dei Tos AP; Morosi C; Mariani L; Casali PG; Stacchiotti S
Oncologist; 2020 Nov; 25(11):e1777-e1784. PubMed ID: 32584482
[TBL] [Abstract] [Full Text] [Related]
16. [Expression of cdk6 and FOXM1 in peripheral T-cell lymphoma and their significance].
Feng HN; Shao XX; Bu P; Zhang F; Wang YJ; Xi YF; Guo WN
Zhonghua Bing Li Xue Za Zhi; 2020 Jun; 49(6):594-600. PubMed ID: 32486537
[No Abstract] [Full Text] [Related]
17. PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.
Chen J; Ge X; Zhang W; Ding P; Du Y; Wang Q; Li L; Fang L; Sun Y; Zhang P; Zhou Y; Zhang L; Lv X; Li L; Zhang X; Zhang Q; Xue K; Gu H; Lei Q; Wong J; Hu W
Theranostics; 2020; 10(7):3151-3163. PubMed ID: 32194860
[TBL] [Abstract] [Full Text] [Related]
18. Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by cdk6-specific PROTACs.
De Dominici M; Porazzi P; Xiao Y; Chao A; Tang HY; Kumar G; Fortina P; Spinelli O; Rambaldi A; Peterson LF; Petruk S; Barletta C; Mazo A; Cingolani G; Salvino JM; Calabretta B
Blood; 2020 Apr; 135(18):1560-1573. PubMed ID: 32040545
[TBL] [Abstract] [Full Text] [Related]
19. Role and mechanism of PTEN in Burkitt's lymphoma.
Li C; Xu Y; Xin P; Zheng Y; Zhu X
Oncol Rep; 2020 Feb; 43(2):481-490. PubMed ID: 31922234
[TBL] [Abstract] [Full Text] [Related]
20. miR-636 represses cell survival by targeting cdk6/Bcl-2 in cervical cancer.
Hu QL; Xu ZP; Lan YF; Li B
Kaohsiung J Med Sci; 2020 May; 36(5):328-335. PubMed ID: 31889428
[TBL] [Abstract] [Full Text] [Related]
[Next]